Definitive Radiotherapy in Node positive Carcinoma Uterine Cervix: A single Institution experience.
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2022 - 2023
Project Lead
Hadrian Noel Alexander
Authors
Alexander, F Hadrian Noel; Udayashankara, Avinash H.; Nirmala, S; Sebastian, M G John; Muzumder, Sandeep; Raju, Jayalekshmi; Tripathy, Arkaja; Ghosh, Santu
Project Status
completed
Project Type
Retrospective cohort study